华纳药厂
(688799)
| 流通市值：40.18亿 | | | 总市值：40.18亿 |
| 流通股本：9380.00万 | | | 总股本：9380.00万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 124,512,903.47 | 177,739,940.58 | 118,093,720.86 | 306,342,845.47 |
| 应收票据及应收账款 | 195,737,160.44 | 187,658,667.02 | 182,617,711.64 | 205,955,821.16 |
| 其中：应收票据 | 29,008,924.84 | 19,351,867.04 | 20,184,305.39 | 13,240,012.82 |
| 应收账款 | 166,728,235.6 | 168,306,799.98 | 162,433,406.25 | 192,715,808.34 |
| 应收款项融资 | 25,172,030.49 | 38,531,030.56 | 22,663,986.88 | 25,400,559.38 |
| 预付款项 | 33,690,712 | 15,220,329.88 | 25,407,635.76 | 18,854,556.15 |
| 其他应收款合计 | 10,928,234.46 | 16,497,508.66 | 2,654,496.44 | 2,158,077.21 |
| 存货 | 416,299,061.19 | 412,431,462.31 | 422,735,855.98 | 400,169,134.13 |
| 其他流动资产 | 403,345,869.34 | 402,193,934.86 | 470,451,803.8 | 474,973,898.94 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,389,685,971.39 | 1,433,272,873.87 | 1,476,625,211.36 | 1,438,854,892.44 |
| 非流动资产: | | | | |
| 长期股权投资 | 72,143,111.74 | 43,494,035.65 | 56,499,072.56 | 63,687,110.27 |
| 投资性房地产 | 5,701,976.44 | 5,744,125.6 | 5,789,044.01 | 5,831,193.17 |
| 固定资产 | 530,360,239.76 | 543,944,507.26 | 557,487,981.54 | 562,707,082.17 |
| 在建工程 | 138,052,477.3 | 143,055,676.31 | 90,984,840.34 | 86,868,585.74 |
| 无形资产 | 184,300,743.98 | 186,093,770.23 | 75,035,431.36 | 74,683,536.65 |
| 商誉 | 32,381,982.12 | 32,381,982.12 | 32,381,982.12 | 32,381,982.12 |
| 长期待摊费用 | 9,877,856.86 | 10,441,791.88 | 6,354,624.95 | 4,860,897.22 |
| 递延所得税资产 | 35,520,848.46 | 39,813,280.04 | 22,453,191.06 | 22,314,671.28 |
| 其他非流动资产 | 72,826,812.04 | 21,399,101.82 | 56,361,349.69 | 36,400,596.68 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,081,166,048.7 | 1,026,368,270.91 | 903,347,517.63 | 889,735,655.3 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,470,852,020.09 | 2,459,641,144.78 | 2,379,972,728.99 | 2,328,590,547.74 |
| 流动负债: | | | | |
| 短期借款 | 2,647,715.21 | 3,770,257.75 | 1,122,542.54 | - |
| 应付票据及应付账款 | 120,412,390.36 | 192,278,534.77 | 141,902,548.04 | 141,761,358.74 |
| 其中：应付票据 | 20,000,000 | 32,359,369.21 | 22,359,369.21 | 10,000,000 |
| 应付账款 | 100,412,390.36 | 159,919,165.56 | 119,543,178.83 | 131,761,358.74 |
| 预收款项 | 9,142,383.57 | 12,539,485.23 | 10,498,840.9 | 7,764,710.05 |
| 合同负债 | 89,292,284.68 | 76,450,375.1 | 74,029,898.93 | 75,161,200.45 |
| 应付职工薪酬 | 15,089,355.48 | 23,435,305.73 | 11,944,575.65 | 11,830,297.23 |
| 应交税费 | 19,780,116.28 | 16,134,036.16 | 6,918,751.48 | 20,753,686.29 |
| 其他应付款合计 | 72,618,637.49 | 74,619,122.09 | 64,295,637.97 | 69,061,735.43 |
| 一年内到期的非流动负债 | 230,849.61 | 51,124.91 | 62,579.07 | 48,864.32 |
| 其他流动负债 | 29,740,359.07 | 19,745,080.46 | 20,177,162.95 | 12,485,852.12 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 358,954,091.75 | 419,023,322.2 | 330,952,537.53 | 338,867,704.63 |
| 非流动负债: | | | | |
| 长期借款 | 134,461,194 | 113,928,338 | 90,809,888 | 69,855,888 |
| 预计负债 | 5,282,000 | 5,282,000 | 5,282,000 | 5,282,000 |
| 递延收益 | 97,415,188.94 | 98,804,349.74 | 45,353,000.34 | 46,881,650.94 |
| 递延所得税负债 | - | 24,102.53 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 237,158,382.94 | 218,038,790.27 | 141,444,888.34 | 122,019,538.94 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 596,112,474.69 | 637,062,112.47 | 472,397,425.87 | 460,887,243.57 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 93,800,000 | 93,800,000 | 93,800,000 | 93,800,000 |
| 资本公积 | 858,606,314.4 | 850,338,381.88 | 850,338,381.88 | 850,338,381.88 |
| 盈余公积 | 46,900,000 | 46,900,000 | 46,900,000 | 46,900,000 |
| 未分配利润 | 853,547,530.68 | 812,368,554.11 | 890,880,306.95 | 845,264,738.99 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,852,853,845.08 | 1,803,406,935.99 | 1,881,918,688.83 | 1,836,303,120.87 |
| 少数股东权益 | 21,885,700.32 | 19,172,096.32 | 25,656,614.29 | 31,400,183.3 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,874,739,545.4 | 1,822,579,032.31 | 1,907,575,303.12 | 1,867,703,304.17 |
| 负债和股东权益合计 | 2,470,852,020.09 | 2,459,641,144.78 | 2,379,972,728.99 | 2,328,590,547.74 |
| 公告日期 | 2025-04-22 | 2025-04-22 | 2024-10-29 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |